These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10847308)

  • 1. Patients with schizophrenia at risk for excessive antipsychotic dosing.
    Walkup JT; McAlpine DD; Olfson M; Labay LE; Boyer C; Hansell S
    J Clin Psychiatry; 2000 May; 61(5):344-8. PubMed ID: 10847308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive antipsychotic dosing in 2 U.S. State hospitals.
    Diaz FJ; De Leon J
    J Clin Psychiatry; 2002 Nov; 63(11):998-1003. PubMed ID: 12444813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
    Valenstein M; Copeland LA; Owen R; Blow FC; Visnic S
    J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
    Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
    Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drug doses in a schizophrenia inpatient unit.
    Galletly CA
    Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
    Shi L; Ascher-Svanum H; Zhu B; Faries D; Montgomery W; Marder SR
    Psychiatr Serv; 2007 Apr; 58(4):482-8. PubMed ID: 17412849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.
    Kroken RA; Johnsen E; Ruud T; Wentzel-Larsen T; Jørgensen HA
    BMC Psychiatry; 2009 May; 9():24. PubMed ID: 19445700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia.
    Sohler NL; Walkup J; McAlpine D; Boyer C; Olfson M
    Psychiatr Serv; 2003 Sep; 54(9):1258-63. PubMed ID: 12954943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder.
    Fleck DE; Hendricks WL; DelBello MP; Strakowski SM
    J Clin Psychiatry; 2002 Aug; 63(8):658-64. PubMed ID: 12197445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using an explicit guideline-based criterion and implicit review to assess antipsychotic dosing performance for schizophrenia.
    Owen RR; Thrush CR; Hudson TJ; Mallory SR; Fischer EP; Clardy JA; Williams DK
    Int J Qual Health Care; 2002 Jun; 14(3):199-206. PubMed ID: 12108530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.
    Kogut SJ; Yam F; Dufresne R
    J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
    Humberstone V; Wheeler A; Lambert T
    Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
    Weinmann S; Janssen B; Gaebel W
    J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
    Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
    Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
    Taylor DM; Young CL; Mace S; Patel MX
    J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia.
    Brown JD; Barrett A; Caffery E; Hourihan K; Ireys HT
    Psychiatr Serv; 2014 Jan; 65(1):121-4. PubMed ID: 24382765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients.
    Ascher-Svanum H; Peng X; Faries D; Montgomery W; Haddad PM
    BMC Psychiatry; 2009 Jul; 9():46. PubMed ID: 19640279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.